Real-world adjuvant treatment patterns in Chinese patients with resected stages I to III EGFR-mutated NSCLC: A multicenter observational study (ADDRESS, CATO-2001)
第一作者机构:[1]Guangzhou Med Univ, Affiliated Hosp 1, Thorac Oncol, State Key Lab Resp Dis,Natl Ctr Resp Med,Natl Clin, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714):
Liang W.,Jiang S.,Chen P.,et al.Real-world adjuvant treatment patterns in Chinese patients with resected stages I to III EGFR-mutated NSCLC: A multicenter observational study (ADDRESS, CATO-2001)[J].JOURNAL OF THORACIC ONCOLOGY.2025,20(3):
APA:
Liang, W.,Jiang, S.,Chen, P.,Chai, Y.,Liu, W....&He, J..(2025).Real-world adjuvant treatment patterns in Chinese patients with resected stages I to III EGFR-mutated NSCLC: A multicenter observational study (ADDRESS, CATO-2001).JOURNAL OF THORACIC ONCOLOGY,20,(3)
MLA:
Liang, W.,et al."Real-world adjuvant treatment patterns in Chinese patients with resected stages I to III EGFR-mutated NSCLC: A multicenter observational study (ADDRESS, CATO-2001)".JOURNAL OF THORACIC ONCOLOGY 20..3(2025)